BRNS
Barinthus Biotherapeutics
BRNS
BRNS
15 hedge funds and large institutions have $60.2M invested in Barinthus Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% less funds holding
Funds holding: 19 → 15 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$167K | |
| 2 | +$129K | |
| 3 | +$113K | |
| 4 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$44.1K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$839K | |
| 3 | -$637K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$624K |
| 5 |
Squarepoint
New York
|
-$420K |